PMC:7128678 / 22335-22540 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"731","span":{"begin":84,"end":94},"obj":"Species"},{"id":"733","span":{"begin":45,"end":51},"obj":"Chemical"},{"id":"734","span":{"begin":114,"end":126},"obj":"Chemical"},{"id":"735","span":{"begin":144,"end":147},"obj":"Chemical"},{"id":"736","span":{"begin":183,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A731","pred":"tao:has_database_id","subj":"731","obj":"Tax:2697049"},{"id":"A734","pred":"tao:has_database_id","subj":"734","obj":"MESH:D005732"},{"id":"A735","pred":"tao:has_database_id","subj":"735","obj":"MESH:D005677"},{"id":"A736","pred":"tao:has_database_id","subj":"736","obj":"MESH:D005677"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T510","span":{"begin":84,"end":94},"obj":"SP_7"},{"id":"T511","span":{"begin":98,"end":113},"obj":"GO:0005886"},{"id":"T512","span":{"begin":114,"end":126},"obj":"CHEBI:16856;CHEBI:16856"},{"id":"T513","span":{"begin":148,"end":155},"obj":"GO:0032991"},{"id":"T514","span":{"begin":178,"end":182},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T515","span":{"begin":187,"end":194},"obj":"GO:0032991"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T146","span":{"begin":98,"end":113},"obj":"Body_part"},{"id":"T147","span":{"begin":114,"end":126},"obj":"Body_part"}],"attributes":[{"id":"A146","pred":"fma_id","subj":"T146","obj":"http://purl.org/sig/ont/fma/fma63841"},{"id":"A147","pred":"fma_id","subj":"T147","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T99","span":{"begin":84,"end":92},"obj":"Disease"},{"id":"T100","span":{"begin":140,"end":143},"obj":"Disease"}],"attributes":[{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A101","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T176","span":{"begin":9,"end":12},"obj":"http://purl.obolibrary.org/obo/PR_000001343"},{"id":"T177","span":{"begin":98,"end":104},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T178","span":{"begin":105,"end":113},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T179","span":{"begin":176,"end":177},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T517","span":{"begin":114,"end":126},"obj":"Chemical"},{"id":"T518","span":{"begin":144,"end":147},"obj":"Chemical"},{"id":"T521","span":{"begin":178,"end":182},"obj":"Chemical"},{"id":"T522","span":{"begin":183,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A517","pred":"chebi_id","subj":"T517","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A518","pred":"chebi_id","subj":"T518","obj":"http://purl.obolibrary.org/obo/CHEBI_18216"},{"id":"A519","pred":"chebi_id","subj":"T518","obj":"http://purl.obolibrary.org/obo/CHEBI_61048"},{"id":"A520","pred":"chebi_id","subj":"T518","obj":"http://purl.obolibrary.org/obo/CHEBI_73110"},{"id":"A521","pred":"chebi_id","subj":"T521","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A522","pred":"chebi_id","subj":"T522","obj":"http://purl.obolibrary.org/obo/CHEBI_18216"},{"id":"A523","pred":"chebi_id","subj":"T522","obj":"http://purl.obolibrary.org/obo/CHEBI_61048"},{"id":"A524","pred":"chebi_id","subj":"T522","obj":"http://purl.obolibrary.org/obo/CHEBI_73110"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T27","span":{"begin":144,"end":147},"obj":"GlycoEpitope"},{"id":"T28","span":{"begin":183,"end":186},"obj":"GlycoEpitope"}],"attributes":[{"id":"A27","pred":"glyco_epitope_db_id","subj":"T27","obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"A28","pred":"glyco_epitope_db_id","subj":"T28","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}

{"project":"LitCovid-sentences","denotations":[{"id":"T185","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With the aim of establishing whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, the initial NTD–GM1 complex was superposed with a drug–GM1 complex (Fig. 9 )."}